Reasons for discontinuation vary by psoriasis treatment
The reasons for discontinuation of commonly used treatments for psoriasis vary by treatment, according to a study published online July 30 in the Journal of the American Academy of Dermatology.
(HealthDay) -- The reasons for discontinuation of commonly used treatments for psoriasis vary by treatment, according to a study published online July 30 in the Journal of the American Academy of Dermatology.
Howa Yeung, from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues conducted interviews of 1,095 patients with moderate-to-severe plaque psoriasis to assess 11 reasons for treatment discontinuation for all past treatments (2,231 total).
The authors found that the median treatment duration ranged from 6.0 to 20.5 months (P < 0.001). For each treatment there was a significantly different frequency of each reason cited for discontinuation. A loss of efficacy was more likely to be cited by patients who received etanercept (odds ratio [OR], 5.19) and adalimumab (OR, 2.10) than by those who received methotrexate. Side effects were less likely to be cited by patients who received etanercept (OR, 0.34), adalimumab (OR, 0.48), or ultraviolet B phototherapy (OR, 0.21) than by those who received methotrexate, and were more likely to be cited by those who received acitretin (OR, 1.56). Inability to afford treatment was more likely to be cited by patients who underwent ultraviolet B phototherapy (OR, 7.03).
"A broad range of clinically relevant, patient-oriented reasons may explain why patients discontinue treatments," the authors write. "These results may inform the development of public policy and evidence-based strategies to improve treatment satisfaction and to maintain successful long-term psoriasis control."
Several authors disclosed financial ties to the pharmaceutical industry.
More information: Abstract
Full Text (subscription or payment may be required)
Journal reference: Journal of the American Academy of Dermatology
Copyright © 2012 HealthDay. All rights reserved.
- UVB preferred for treatment of moderate to severe psoriasis Feb 24, 2012 | not rated yet | 0
- Study compares effectiveness of psoriasis treatments Apr 20, 2012 | not rated yet | 0
- Short/long-term analyses deem etanercept safe for psoriasis Jul 29, 2012 | not rated yet | 0
- Newer, more expensive psoriasis drugs only slightly more effective than older therapies under real world conditions Apr 30, 2012 | not rated yet | 0
- Many psoriasis patients undertreated for CV risk factors Jun 22, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
Diseases, Conditions, Syndromes 15 hours ago | not rated yet | 0
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0
(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.
Diseases, Conditions, Syndromes 17 hours ago | not rated yet | 0
Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.
Diseases, Conditions, Syndromes 20 hours ago | not rated yet | 0
The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.
Diseases, Conditions, Syndromes May 24, 2013 | 5 / 5 (1) | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
21 hours ago | 5 / 5 (3) | 0 |
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
15 hours ago | 3 / 5 (2) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
18 hours ago | 3.7 / 5 (3) | 0 |
Ernie Pyle – an iconic war correspondent in World War II – reportedly said "There are no atheists in foxholes." A new joint study between two brothers at Cornell and Virginia Wesleyan found that only ...
21 hours ago | 2.5 / 5 (4) | 2
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
21 hours ago | 4 / 5 (2) | 2
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
18 hours ago | 5 / 5 (5) | 0 |